256 results on '"TAMAI, Toshiyuki"'
Search Results
2. Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trial
3. Comparison of safety outcomes of anticancer drugs in Japanese and non-Japanese patients in multi-regional clinical trials: meta-analysis of safety profiles
4. Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT StudyBiomarker Analysis Following Lenvatinib in Unresectable HCC
5. Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study
6. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial
7. Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT
8. Comparison of efficacy outcomes of anticancer drugs between Japanese patients and the overall population
9. Analysis of tumor biomarkers in patients (pts) with advanced hepatocellular carcinoma (HCC) from a phase 1b study of E7386, a CREB-binding protein/β-catenin interaction inhibitor, in combination with lenvatinib.
10. Properties of surface layers of polyethylene naphthalate substrates modified by ultraviolet light irradiation for their electroless deposition
11. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
12. REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset
13. Polydopamine-Coated Solid Silica Nanoparticles Encapsulating IR-783 Dyes: Synthesis and NIR Fluorescent Cell Imaging.
14. Near-Infrared Dye Immobilized in Porous Silica Layer on Gold Nanorod and Its Fluorescence Enhancement by Strengthened Electromagnetic Field Based on Surface Plasmon Resonance
15. Case Note on the Judgment of the Tokyo District Court on September 2, 2015
16. Supplementary Figure 1 from Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
17. Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma
18. A phase 1 study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in patients (pts) with advanced solid tumors including colorectal cancer: Updated dose-escalation part.
19. Highly c-axis oriented deposition of zinc oxide on an ITO surface modified by layer-by-layer method
20. 'Fair M&A Guidelines' and MBOs
21. Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure–Response Analyses
22. Modification of PEN and PET film surfaces by plasma treatment and layer-by-layer assembly of polyelectrolyte multilayer thin films
23. Estimation of uniformity in Schottky contacts between printed Ni electrode and n-GaN by scanning internal photoemission microscopy
24. Impact of bodyweight‐based starting doses on the safety and efficacy of lenvatinib in primarily Japanese patients with hepatocellular carcinoma
25. Abstract CT523: An open-label, multicenter, phase 1b/2 Study of E7386 (Wnt/β-catenin pathway inhibitor) + pembrolizumab in patients with pretreated advanced solid tumors
26. 'Fair M&A Guidelines' and Freezeout Transactions(2)
27. Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies
28. A fusion protein N-cadherin-Fc as an artificial extracellular matrix surface for maintenance of stem cell features
29. Helically aligned fused carbon hollow nanospheres with chiral discrimination ability
30. Room-temperature coalescence of Pd nanoparticles with sacrificial templates and sintering agents, and their catalytic activities in the Suzuki coupling reaction
31. M&A Transactions and Injunctive Relief
32. Hybrid films prepared from latex particles incorporating metal oxide nanoparticles
33. Surface Modification and Electroless Deposition of Flexible Polymer Substrates
34. Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study.
35. Impact of bodyweight (BW)-based starting doses on safety and efficacy of lenvatinib (LEN) in patients (pts) with hepatocellular carcinoma (HCC).
36. Room-Temperature Coalescence of Tri-n-Octylphosphine-Oxide-Capped Cu-Ag Core-Shell Nanoparticles: Effect of Sintering Agent and/or Reducing Agent
37. Baseline Liver Function and Subsequent Outcomes in the Phase 3 REFLECT Study of Patients with Unresectable Hepatocellular Carcinoma
38. Printed Silver Electrode for Silicon-based Schottky Barrier Diode: High Rectification Ratio Enabled by Ag/p-Si Interface Exceeds Theoretical Barrier Height
39. Comparison of efficacy outcomes of anticancer drugs between Japanese patients and the overall population
40. Two-Dimensional Characterization of n-GaN Schottky Contacts Printed by Using Ni Nanoink
41. Crystal structure of 7,7′-[(pyridin-2-yl)methylene]bis(5-chloroquinolin-8-ol)
42. M&A Transactions and Injunctive Relief(2)
43. Generation of polyphenylene radical cations and their cosensitization ability in the 9,10-dicyanoanthracene-sensitized photochemical chain reactions of 1,2-bis(4-methoxyphenyl)cyclopropane
44. Photooxygenation of 1,omega-bis(diarylethenyl)alkanes via photoinduced electron-transfer: formation of 1,4-radical cations and its trapping by molecular dioxygen
45. Photoinduced electron transfer reactions of organosilicon compounds
46. Salt effect of the 9,10-dicyanoanthracene-sensitized photooxygenation of 1,2-diarylcyclopropanes and the photodecomposition of 3,5-diaryl-1,2-dioxolanes
47. Insertion of nitrogen oxide and nitrosonium ion into the cyclopropane ring: a new route to 2-isoxazolines and its mechanistic studies
48. Baseline liver function and outcomes in the phase III REFLECT study in patients with unresectable hepatocellular carcinoma (uHCC).
49. Overall Survival and Objective Response in Advanced Unresectable Hepatocellular Carcinoma: A Subanalysis of the REFLECT Study
50. REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.